全文获取类型
收费全文 | 46156篇 |
免费 | 1339篇 |
国内免费 | 205篇 |
专业分类
耳鼻咽喉 | 347篇 |
儿科学 | 1787篇 |
妇产科学 | 1011篇 |
基础医学 | 4950篇 |
口腔科学 | 1998篇 |
临床医学 | 4089篇 |
内科学 | 8404篇 |
皮肤病学 | 893篇 |
神经病学 | 2528篇 |
特种医学 | 868篇 |
外科学 | 7119篇 |
综合类 | 4122篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 5279篇 |
眼科学 | 718篇 |
药学 | 2048篇 |
138篇 | |
中国医学 | 397篇 |
肿瘤学 | 1001篇 |
出版年
2024年 | 185篇 |
2023年 | 389篇 |
2022年 | 573篇 |
2021年 | 1064篇 |
2020年 | 708篇 |
2019年 | 6445篇 |
2018年 | 4861篇 |
2017年 | 2600篇 |
2016年 | 649篇 |
2015年 | 531篇 |
2014年 | 1321篇 |
2013年 | 1375篇 |
2012年 | 1347篇 |
2011年 | 1360篇 |
2010年 | 1073篇 |
2009年 | 1000篇 |
2008年 | 1059篇 |
2007年 | 1040篇 |
2006年 | 786篇 |
2005年 | 519篇 |
2004年 | 405篇 |
2003年 | 296篇 |
2002年 | 236篇 |
2001年 | 190篇 |
2000年 | 181篇 |
1999年 | 118篇 |
1998年 | 77篇 |
1997年 | 73篇 |
1996年 | 78篇 |
1995年 | 75篇 |
1994年 | 77篇 |
1993年 | 42篇 |
1992年 | 48篇 |
1991年 | 44篇 |
1990年 | 36篇 |
1989年 | 30篇 |
1988年 | 40篇 |
1985年 | 1451篇 |
1984年 | 2271篇 |
1983年 | 1583篇 |
1982年 | 1701篇 |
1981年 | 1623篇 |
1980年 | 1402篇 |
1979年 | 1389篇 |
1978年 | 1145篇 |
1977年 | 873篇 |
1976年 | 1023篇 |
1975年 | 838篇 |
1974年 | 748篇 |
1973年 | 685篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461
Background
The purpose of the study was to evaluate the association between fetal echocardiographic measurements and the need for intervention (primary coarctation repair, staged coarctation repair, or catheter intervention) in prenatally diagnosed coarctation of the aorta.Methods
A single-centre retrospective cohort study (2005-2015) of 107 fetuses diagnosed with suspected coarctation of the aorta in the setting of an apex-forming left ventricle and antegrade flow across the mitral and aortic valves.Results
Median gestational age at diagnosis was 32 weeks (interquartile range, 23-35 weeks). Fifty-six (52%) did not require any neonatal intervention, 51 patients (48%) underwent a biventricular repair. In univariable analysis, an increase in ascending aorta (AAo) peak Doppler flow velocity (odds ratio [OR], 1.40 [95% confidence interval [CI], 1.05-1.91] per 20 cm/s; P = 0.03) was associated with intervention. No intervention was associated with larger isthmus size (OR, 0.23; P < 0.001), transverse arch diameter (OR, 0.23; P < 0.001), and aortic (OR, 0.72; P = 0.02), mitral (OR, 0.58; P = 0.001), and AAo (OR, 0.53; P < 0.001) z-scores. In multivariable analysis, higher peak AAo Doppler (OR, 2.51 [95% CI, 1.54-4.58] per 20 cm/s; P = 0.001) and younger gestational age at diagnosis (OR, 0.81 [95% CI, 0.70-0.93] per week; P = 0.005) were associated with intervention, whereas a higher AAo z-score (OR, 0.65 [95% CI, 0.43-0.94] per z; P = 0.029) and transverse arch dimension (OR, 0.44 [95% CI, 0.18-0.97]; P = 0.05) decreased the risk of intervention.Conclusions
In prenatally suspected coarctation, the variables associated with intervention comprised smaller AAo and transverse arch size, earlier gestational age at diagnosis, and the additional finding of a higher peak AAo Doppler. 相似文献2.
Kyle E. Embertson Diann M. Krywko Eric R. Bunch 《The American journal of emergency medicine》2019,37(5):1005.e3-1005.e4
Nephrolithiasis is a common pathology encountered in the primary care and emergency department (ED) setting. In 2009 alone, there were over one million ED visits related to nephrolithiasis Higa et al. (2017) [1]. Emergent treatment options range from non-invasive pain control and patient education to lithotripsy and other invasive urologic procedures depending on stone location and related pathology. Urethral calculi are estimated to represent 0.3% of all urinary stone diseases Verit et al. (2006) [2]. There are very few case reports documenting distal urethral stone removal in the ED. Here we present a case of distal urethral stone impaction and the removal of this stone by ED providers, leading to expedited care and prevention of consultation and possible admission. 相似文献
3.
P. Mendogni S. Henchi L.C. Morlacchi D. Tosi M. Nosotti P. Tarsia A.I. Gregorini L. Rosso 《Transplantation proceedings》2019,51(1):194-197
Background
Solid organ transplantation is associated with a higher risk of Epstein-Barr virus (EBV)–related lymphoproliferative disease due to immunosuppressive regimen. Little evidence is currently available on post-transplant lymphoproliferative disorders (PTLDs) in the lung transplant (LuTx) setting, particularly in cystic fibrosis (CF) recipients.Methods
We retrospectively analyzed all the cases of PTLDs that occurred in our LuTx center between January 2015 and December 2017. We reviewed clinical and radiologic data, donor and recipient EBV serostatus, immunosuppressive therapy, histologic data, and follow-up of these patients.Results
A total of 77 LuTxs were performed at our center in the study period; 39 (50.6%) patients had CF; 4 developed EBV-related PTLDs. They were all young (17–26 years) CF patients with high serum EBV DNA load. Disease onset was within the first 3 months after LuTx. In 3 cases presentation was associated with fever and infection-like symptoms, whereas in 1 case radiologic suspicion arose unexpectedly from a CT scan performed for different clinical reasons. Diagnosis was reached through lung biopsy in all cases. All patients received rituximab,?cyclophosphamide, doxorubicin hydrochloride (hydroxydaunomycin), vincristine sulfate (Oncovin), and prednisone with variable response and complications.Conclusion
In our experience, the early development of EBV-related PTLD was a highly aggressive, life-threatening condition, which exclusively affected young CF patients in the early post-transplant period. The rate of this complication was relatively high in our population.Diagnosis with lung biopsy is crucial in all suspected cases and regular monitoring of EBV DNA levels is of utmost importance given the high correlation with PTLDs in patients at increased risk. 相似文献4.
Elizabeth D. Krebs William Z. Chancellor Jared P. Beller J. Hunter Mehaffey Robert B. Hawkins Robert G. Sawyer Leora T. Yarboro Gorav Ailawadi Nicholas R. Teman 《The Annals of thoracic surgery》2021,111(2):594-599
- Download : Download high-res image (247KB)
- Download : Download full-size image
5.
Kristen E. Rhodin Vignesh Raman Oliver K. Jawitz Soraya L. Voigt Norma E. Farrow David H. Harpole Betty C. Tong Thomas A. D’Amico 《The Annals of thoracic surgery》2021,111(2):440-447
- Download : Download high-res image (251KB)
- Download : Download full-size image
6.
D. Adkins J. Ley P. Oppelt H.A. Gay M. Daly R.C. Paniello R. Jackson P. Pipkorn J. Rich J. Zevallos K. Trinkaus W. Thorstad 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(9):e123-e131
AimsOrgan preservation, an important goal in the treatment of head and neck squamous cell carcinoma (HNSCC), may include induction chemotherapy and cisplatin with radiation therapy (CRT). To our knowledge, no reports have directly compared the impact of induction chemotherapy with that of CRT on health-related quality of life (HRQOL).Materials and methodsIn a phase II trial, we assessed the HRQOL of patients treated with induction chemotherapy followed by CRT. Eligible patients had stage III–IV HNSCC. HRQOL questionnaires were administered at baseline, the end of induction (EOI), the end of CRT (EOCRT) and after CRT. Functional Assessment of Cancer Therapy (FACT version 4) assessed HRQOL. We carried out a comparison of changes in HRQOL from baseline to EOI and from EOI to EOCRT. This trial is registered with ClinicalTrials.gov (NCT01566435).ResultsThirty patients were enrolled in the study. Most HRQOL questionnaires were completed (88%). The mean total FACT scores did not differ from baseline to EOI (general: 83.8 versus 79.1, P = 0.08; head and neck: 109.7 versus 105.8, P = 0.33; Total Outcome Index: 69.7 versus 62.3, P = 0.03; respectively, using P ≤ 0.01 to adjust for multiple simultaneous tests of differences). However, total FACT scores significantly worsened from EOI to EOCRT (79.1 versus 62.3, P = 0.01; 105.8 versus 74.2, P < 0.01; 62.3 versus 34.2, P = 0.01; respectively). Within domains, the head and neck cancer subscale score did not differ from baseline to EOI (median 28.5 versus 27.0, P = 0.69), but significantly worsened from EOI to EOCRT (27.0 versus 9.5, P < 0.01). Swallowing, oral pain and voice quality improved from baseline to EOI, but worsened from EOI to EOCRT. Physical and functional scores worsened from baseline to EOI and from EOI to EOCRT. The emotional well-being score improved from baseline to EOI but worsened from EOI to EOCRT.ConclusionsOverall, HRQOL did not significantly change from baseline to EOI but dramatically worsened from EOI to EOCRT. 相似文献
7.
8.
J.C. Rodríguez-Sanjuán N. Ruiz E. Miñambres E. Toledo M. González-Noriega R. Fernández-Santiago F. Castillo 《Transplantation proceedings》2019,51(1):12-19
Background
Liver transplantation from donors after either controlled or uncontrolled cardiac death (DCD) is associated with considerable rates of primary nonfunction (PNF) and ischemic cholangiopathy (IC). Normothermic regional perfusion (NRP) could significantly reduce such rates.Methods
Retrospective study to analyze short-term (mortality, PNF, vascular complications) and long-term (IC, survival) complications in 11 liver transplants from controlled DCDs using NRP with extracorporeal membrane oxygenation (ECMO) (group 1). They were compared with 51 patients transplanted with grafts from donors after brain death (DBD) (group 2). Mean recipient age, sex, and Model for End-stage Liver Disease (MELD) score were not significantly different.Results
In group 1, mean functional warm ischemia time was 15.8 (range, 7–40) minutes and 94.1 (range, 20–150) minutes on NRP. The ischemic damage was minimal, as shown by the slight alanine aminotransferase (ALT) and aspartate aminotransferase (AST) rises in the donor serum after 1 hour on NRP and similar rises 24 hours after transplantation in both groups. No patient had IC or acute renal failure. No significant difference was found between the groups for vascular or biliary complications. One group 1 patient had PNF (9.1%), resulting in death. Overall retransplantation and in-hospital death rates were 8.1% and 4.8%, respectively, with no significant difference between groups. Estimated mean survival was 24.6 (95% confidence interval [CI], 20.2–29.1) months in group 1 and 32.3 (95% CI, 30.4–34.2) months in group 2 (not a statistically significant difference).Conclusion
In our experience, liver transplants from controlled DCDs using NRP with ECMO is associated with a low risk of PNF and IC, with short- and long-term results comparable to those in DBD transplants. 相似文献9.
10.